Form 4: Genprex Chief Medical Officer Awarded Restricted Stock Units

Genprex's Chief Medical Officer, Mark Stanley Berger, was granted 18,250 restricted stock units (RSUs) that will vest on June 30, 2025.

Summary

• Mark Stanley Berger, the Chief Medical Officer of Genprex, Inc., was awarded 18,250 restricted stock units (RSUs) on December 5, 2024.
• These RSUs were granted under the company's 2018 Equity Incentive Plan.
• The RSUs will vest 100% on June 30, 2025, provided Mr. Berger remains a service provider to the company.
• Upon vesting, each RSU will convert into one share of Genprex's common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The grant of RSUs aligns the Chief Medical Officer's interests with the company's long-term success.
• The vesting schedule encourages continued service and commitment from the executive.

Risks

• The value of the RSUs is dependent on the future stock price of Genprex, which is subject to market fluctuations.
• If Mr. Berger leaves the company before the vesting date, he will forfeit the unvested RSUs.

Future Outlook

The vesting of the RSUs is contingent on the continued service of the recipient through June 30, 2025.

Industry Context

The granting of stock-based compensation is a common practice in the biotechnology industry to attract and retain key executives.

Comparison to Industry Standards

• Stock-based compensation, such as RSUs, is a standard practice for incentivizing executives in the biotech sector.
• Vesting schedules, like the one described, are typical to ensure long-term commitment from key personnel.
• Many biotech companies use similar equity plans to align executive interests with shareholder value.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the Chief Medical Officer to contribute to the company's success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Restricted Stock Units, RSUs, Equity Incentive Plan, Genprex, Mark Stanley Berger, Chief Medical Officer, Stock Award, Vesting